mRNA expression, tumor heterogeneity, and response to therapy in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1α)

Background: Renal Cell Carcinoma (RCC) represents a spectrum of tumors, characterized by heterogeneous growth patterns, histology and response to immune-based combinations. Objectives: The aim of the present retrospective analysis was to investigate the mRNA expression of 32 genes associated with RC...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Cristina Aguzzi, Simona De Summa, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Massimo Nabissi, Mimma Rizzo, Annalisa Zeppellini, Kaisa Sunela, Giulia Sorgentoni, Cinzia Ortega, Francesco Massari, Fernando Sabino Marques Monteiro, Nicola Battelli, Camillo Porta, Giorgio Santoni, Matteo Santoni
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2025-09-01
Schriftenreihe:	Biochemistry and Biophysics Reports
Schlagworte:	Axitinib Cabozantinib Gene profiles Immune-based combinations Lenvatinib Nivolumab
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2405580825002493
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!